Different types of NPM1 mutations in children and adults: Evidence for an effect of patient age on the prevalence of the TCTG-tandem duplication in NPM1-exon 12 [8]

Leukemia

Volumn 21, Issue 2, 2007, Pages 366-367

  Thiede, Christian ^a   Creutzig, E ^a   Reinhardt, D ^b   Ehninger, G ^a   Creutzig, U ^c  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; DNA FRAGMENT; FLT3 LIGAND; GUANINE; NUCLEOPHOSMIN; THYMINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGE DISTRIBUTION; ALLOGENEIC STEM CELL TRANSPLANTATION; CHILD; CONTROLLED STUDY; DNA EXTRACTION; EXON; FEMALE; FREQUENCY ANALYSIS; GENDER BIAS; GENE MUTATION; GENETIC SCREENING; HUMAN; KARYOTYPE; LETTER; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; SEQUENCE ANALYSIS; TANDEM REPEAT;

EID: 33846475525     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404519     Document Type: Letter

References (7)

1. Falini B, Nicoletti I, Martelli MF, Mecucci C. Invited review: Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NMPc+ AML): biological and clinical features. Blood 2006 (E-pub doi 10.1182).
2. Falini B, Bolli N, Shan J, Martelli MP, Liso A, Pucciarini A et al. Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. Blood 2006; 107: 4514-4523.
3. Thiede C, Creutzig E, Illmer T, Schaich M, Heiser V, Ehninger G et al. Rapid and sensitive typing of NPM1 mutations using LNA-mediated PCR clamping. Leukemia 2006; 20: 1897-1899.
4. Cazzaniga G, Dell'oro MG, Mecucci C, Giarin E, Masetti R, Rossi V et al. Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype. Blood 2005; 106: 1419-1422.
5. Chou WC, Tang JL, Lin LI, Yao M, Tsay W, Chen CY et al. Nucleophosmin mutations in de novo acute myeloid leukemia: The age-dependent incidences and the stability during disease evolution. Cancer Res 2006; 66: 3310-3316.
6. Creutzig U, Zimmermann M, Lehrnbecher T, Graf N, Hermann J, Niemeyer CM et al. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: Results of AML-BFM 98. J Clin Oncol 2006; 24: 4499-4506.
7. Thiede C, Koch S, Creutzig E, Steudel C, Illmer T, Schaich M et al. Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). Blood 2006; 107: 4011-4020.